Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
May 2009 - Prostate; 69(9):1097-0045 [PMID:19267351]
[Kim S] [Lee JB] [Lee GK] [Chang J]